Sign in

CIK 0001858848

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Tenaya Therapeutics, Inc.

Sign in to watch
Ticker
TNYA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813789973
Phone
+1 415-865-2066
Business address
171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-08-03 COLUMN GROUP III GP, LP 10% owner Conversion · Series A Preferred Stock −3,727,742 0
2021-08-03 COLUMN GROUP III GP, LP 10% owner Conversion · Series A Preferred Stock −4,209,755 0
2021-08-03 COLUMN GROUP III GP, LP 10% owner Conversion · Series B Preferred Stock −472,659 0
2021-08-03 COLUMN GROUP III GP, LP 10% owner Conversion · Series B Preferred Stock −533,781 0
2021-08-03 COLUMN GROUP III GP, LP 10% owner Conversion · Series C Preferred Stock −188,881 0
2021-08-03 COLUMN GROUP III GP, LP 10% owner Conversion · Series C Preferred Stock −213,306 0
2021-08-03 Casdin Partners Master Fund, L.P. 10% owner Conversion +2,374,849 2,374,849
2021-08-03 Casdin Partners Master Fund, L.P. 10% owner Purchase +850,000 $15.00 $12.8M 3,224,849
2021-08-03 Casdin Partners Master Fund, L.P. 10% owner Conversion +361,969 361,969
2021-08-03 Casdin Partners Master Fund, L.P. 10% owner Conversion · Series B Preferred Stock −2,012,880 0
2021-08-03 Casdin Partners Master Fund, L.P. 10% owner Conversion · Series C Preferred Stock −361,969 0
2021-08-03 Casdin Partners Master Fund, L.P. 10% owner Conversion · Series C Preferred Stock −361,969 0
2021-08-03 Casdin Eli Director Conversion +2,374,849 2,374,849
2021-08-03 Casdin Eli Director Purchase +850,000 $15.00 $12.8M 3,224,849
2021-08-03 Casdin Eli Director Conversion +361,969 361,969
2021-08-03 Casdin Eli Director Conversion · Series B Preferred Stock −2,012,880 0
2021-08-03 Casdin Eli Director Conversion · Series C Preferred Stock −361,969 0
2021-08-03 Casdin Eli Director Conversion · Series C Preferred Stock −361,969 0
2021-08-03 GOEDDEL DAVID V Director Conversion +4,389,282 4,414,720
2021-08-03 GOEDDEL DAVID V Director Conversion +4,956,842 4,985,570

Page 11 of 12 · 228 trades